<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>06931861100254</udiDi>
    <basicUdiDi>69318611ophtha0012H</basicUdiDi>
    <tradeName>Survisc®</tradeName>
    <deviceName>Sterile Medical Sodium Hyaluronate</deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co.,Ltd</manufacturerName>
    <manufacturerSrn>CN-MF-000023601</manufacturerSrn>
    <authorisedRepresentativeName>Medical Technology Promedt Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000085</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>15mg/mL-1.0mL</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-02T06:48:22.755Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861100797</udiDi>
    <basicUdiDi>69318611ophtha0012H</basicUdiDi>
    <tradeName>Survisc®</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co.,Ltd</manufacturerName>
    <manufacturerSrn>CN-MF-000023601</manufacturerSrn>
    <authorisedRepresentativeName>Medical Technology Promedt Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000085</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>15mg/mL-0.85mL</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-24T05:45:05.820Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861100759</udiDi>
    <basicUdiDi>69318611ophtha0012H</basicUdiDi>
    <tradeName>Survisc®</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co.,Ltd</manufacturerName>
    <manufacturerSrn>CN-MF-000023601</manufacturerSrn>
    <authorisedRepresentativeName>Medical Technology Promedt Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000085</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>15mg/mL-0.55mL</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-24T05:45:04.620Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861100605</udiDi>
    <basicUdiDi>69318611ophtha0012H</basicUdiDi>
    <tradeName>Survisc®</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co.,Ltd</manufacturerName>
    <manufacturerSrn>CN-MF-000023601</manufacturerSrn>
    <authorisedRepresentativeName>Medical Technology Promedt Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000085</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>15mg/mL-0.4mL</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-24T05:45:02.223Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861100391</udiDi>
    <basicUdiDi>69318611ophtha0012H</basicUdiDi>
    <tradeName>Survisc®Plus</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co.,Ltd</manufacturerName>
    <manufacturerSrn>CN-MF-000023601</manufacturerSrn>
    <authorisedRepresentativeName>Medical Technology Promedt Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000085</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>20mg/mL-1.0mL</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-24T05:45:01.008Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861100384</udiDi>
    <basicUdiDi>69318611ophtha0012H</basicUdiDi>
    <tradeName>Survisc®Plus</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co.,Ltd</manufacturerName>
    <manufacturerSrn>CN-MF-000023601</manufacturerSrn>
    <authorisedRepresentativeName>Medical Technology Promedt Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000085</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>20mg/mL-0.55mL</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-24T05:44:59.820Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861100377</udiDi>
    <basicUdiDi>69318611ophtha0012H</basicUdiDi>
    <tradeName>Survisc®Plus</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co.,Ltd</manufacturerName>
    <manufacturerSrn>CN-MF-000023601</manufacturerSrn>
    <authorisedRepresentativeName>Medical Technology Promedt Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000085</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>20mg/mL-0.4mL</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-24T05:44:58.604Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861100261</udiDi>
    <basicUdiDi>69318611ophtha0012H</basicUdiDi>
    <tradeName>Survisc®Plus</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co.,Ltd</manufacturerName>
    <manufacturerSrn>CN-MF-000023601</manufacturerSrn>
    <authorisedRepresentativeName>Medical Technology Promedt Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000085</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>20mg/mL-0.85mL</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-24T05:44:56.219Z</lastUpdated>
  </row>
</eudamedExport>